NEW YORK and BERLIN, April 17, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company pioneering the...
VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed...
At the recent launch of PsyPal, the first EU-funded clinical research project focused on psychedelic-assisted mental health treatments, MEPs were informed...
At the recent launch of PsyPal, the first EU-funded clinical research project focused on psychedelic-assisted mental health treatments, MEPs were informed...
A collaborative effort among scientists from the University of Texas at Arlington, Scottsdale Research Institute in Phoenix, Shimadzu Scientific Instruments...
Governor Eric Holcomb of Indiana has recently enacted a law that earmarks funds for clinical trials to explore the therapeutic effects of psilocybin. This...
Governor Eric Holcomb of Indiana has recently enacted a law that earmarks funds for clinical trials to explore the therapeutic effects of psilocybin. This...
Diabetes, a chronic condition marked by elevated blood sugar levels, is projected to affect over 700 million people globally by 2045. As the prevalence...